MannKind Corp - Company Profile
Powered by
All the data and insights you need on MannKind Corp in one report.
- Save hours of research time and resources with
our up-to-date MannKind Corp Strategy Report
- Understand MannKind Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
MannKind Corp (Mannkind) focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. The company harnesses its patented Technosphere formulation technology, lead product Afrezza and research and development activities. However, operating loss could be a setback for the company. Nevertheless, the company could find opportunities from the growing incidence of diabetes and growth initiatives. However, competition and rapid changes in technology could impact the company’s operational and financial performance.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer